Interactive Tele-health and Auto-Biofeedback Sensor System for Wheelchair Users

适用于轮椅使用者的交互式远程医疗和自动生物反馈传感器系统

基本信息

  • 批准号:
    8650910
  • 负责人:
  • 金额:
    $ 19.67万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-04-10 至 2016-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The public health problem addressed by this proposal is that inactivity in individuals with chronic disabilities who use a wheelchair results in signifiant and costly secondary complications, such as pressure ulcers, obesity, diabetes, osteoporosis, and cardiovascular comorbidities. We propose an interactive telehealth monitoring and auto-biofeedback system to promote physical activity, pressure relief maneuver performance, and self-management among wheelchair users. In this project we focus on patients with spinal cord injury (SCI) who are at particularly high risk for developing pressure ulcers from sitting too long (31% annual incidence, 85% lifetime incidence). However, the proposed technology is broadly applicable to wheelchair based telehealth. The proposed technology - which attaches to any wheelchair without modification - has three core components: 1) an activity monitoring system (i.e., wheelchair speed, distance travelled, and number of self-propulsions), 2) a pressure relief monitoring system, and 3) a system that provides reminders and feedback regarding the achievement of pressure relief and physical activity goals. Biofeedback will be delivered locally (to the user) via a wheelchair mounted display and remotely (to the clinician) via a secure internet interface. The enabling technologies are innovative sensor systems to monitor wheelchair specific activity patterns but the significant value comes from integrating these novel measurements within biofeedback system that encourages wheelchair users to actively avoid secondary complications of inactivity and allows care providers to identify at risk patients and intervene efficiently. Existing technologies do not compare with the proposed solution. Products exist to monitor wheelchair seat pressure but these products are costly, cumbersome, and not designed for home use. Products exist to monitor wheelchair specific physical activity but these devices cannot distinguish passive from active wheelchair movement. No existing technology combines these measures with auto-biofeedback and telehealth functionality. The team we have assembled for this collaborative project includes engineers, clinicians, and scientists from BioSensics (a privately held biomedical technology development company) and Rancho Los Amigos National Rehabilitation Center (one of the largest comprehensive rehabilitation centers in the United States). In addition, this project benefits from the consultation of a world-renowned expert in physical activity monitoring (Dr. Bijan Najafi, University of Arizona), as well as a leading expert and critical decision maker in SCI care (Dr. Sophia Chun, Chief of SCI, Veterans Health Administration). This team has collaborated successfully on prior projects. The Specific Aims of Phase I are to 1) improve prototyped and pilot tested versions of the proposed system by leveraging existing BioSensics technologies commercialized through prior NIH SBIR awards; 2) validate the measurements of the proposed system using state-of-the-art tools including a high-density pressure mat and camera-based motion capture, and 3) evaluate the efficacy of local biofeedback (to the user via a wheelchair mounted display) during community usage. By demonstrating that biofeedback increases physical activity and achievement of pressure relief will justify further NIH investment in the proposed technology. Within 6 months of the completion of Phase I, we anticipate having a commercially available beta release of the system (BioSensics has successfully brought several products to market in this timeframe). In Phase II we will develop the remote monitoring and telehealth aspects of the proposed system by adding automatic wireless data transfer capabilities (via mobile and Wi-Fi networks) and developing a secure website for remotely accessing activity data and sending telehealth reminders to the wheelchair mounted display.
描述(由申请人提供):本提案所解决的公共卫生问题是,使用轮椅的慢性残疾人的不活动导致严重且昂贵的继发性并发症,如压疮、肥胖、糖尿病、骨质疏松症和心血管合并症。我们提出了一个交互式远程健康监测和自动生物反馈系统,以促进轮椅使用者的身体活动,减压操作性能和自我管理。在这个项目中,我们专注于脊髓损伤(SCI)患者,他们因久坐而患压疮的风险特别高 (31%年发病率,85%终生发病率)。然而,所提出的技术广泛适用于基于轮椅的远程医疗。所提出的技术--不经修改地连接到任何轮椅上--有三个核心组成部分:1)活动监测系统(即,轮椅速度、行进距离和自推进次数),2)压力释放监测系统,以及3)提供关于压力释放和身体活动目标的实现的提醒和反馈的系统。生物反馈将通过安装在轮椅上的显示器在本地(向用户)传递,并通过安全的互联网接口远程(向临床医生)传递。使能技术是监测轮椅特定活动模式的创新传感器系统,但重要的价值来自于将这些新的测量集成到生物反馈系统中,该系统鼓励轮椅使用者积极避免不活动的继发性并发症,并允许护理提供者识别风险患者并进行有效干预。现有技术无法与建议的解决方案相比。存在用于监测轮椅座椅压力的产品,但是这些产品昂贵、笨重,并且不是为家庭使用而设计的。存在用于监测轮椅特定身体活动的产品,但这些设备无法区分被动轮椅运动和主动轮椅运动。现有技术没有将这些措施与自动生物反馈和远程保健功能相结合。我们为这个合作项目组建的团队包括来自BioSensics(一家私营生物医学技术开发公司)和Rancho Los Amigos国家康复中心(美国最大的综合康复中心之一)的工程师,临床医生和科学家。此外,该项目还受益于世界知名的咨询 她是身体活动监测方面的专家(Bijan Najalan博士,亚利桑那大学),也是SCI护理方面的领先专家和关键决策者(Sophia Chun博士,退伍军人健康管理局SCI主任)。该团队在以前的项目中成功合作。第一阶段的具体目标是:1)通过利用先前NIH SBIR奖项商业化的现有BioSensics技术,改进拟议系统的原型和试点测试版本; 2)使用包括高密度压力垫和基于相机的运动捕捉的最先进的工具来验证所提出的系统的测量,以及3)在社区使用期间评估局部生物反馈(通过安装在轮椅上的显示器向用户反馈)的功效。通过证明生物反馈增加了身体活动和压力缓解的实现将证明NIH对拟议技术的进一步投资是合理的。在第一阶段完成后的6个月内,我们预计将有一个商业可用的测试版系统(BioSensics已成功地将几个产品推向市场,在这个时间范围内)。在第二阶段,我们将通过增加自动无线数据传输功能(通过移动的和Wi-Fi网络)和开发一个安全的网站来远程访问活动数据并向轮椅上的显示器发送远程健康提醒,从而开发拟议系统的远程监测和远程健康方面。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Telehealth monitor to measure physical activity and pressure relief maneuver performance in wheelchair users.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joseph T Gwin其他文献

Joseph T Gwin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joseph T Gwin', 18)}}的其他基金

Wearable Sensors for Quantitative Assessment of Motor Impairment in Huntington's Disease
用于定量评估亨廷顿病运动损伤的可穿戴传感器
  • 批准号:
    9409865
  • 财政年份:
    2017
  • 资助金额:
    $ 19.67万
  • 项目类别:
Fracture Risk Assessment Software for Skeletal Metastasis
骨骼转移骨折风险评估软件
  • 批准号:
    9047548
  • 财政年份:
    2016
  • 资助金额:
    $ 19.67万
  • 项目类别:
Interactive Tele-health and Auto-Biofeedback Sensor System for Wheelchair Users
适用于轮椅使用者的交互式远程医疗和自动生物反馈传感器系统
  • 批准号:
    8522697
  • 财政年份:
    2013
  • 资助金额:
    $ 19.67万
  • 项目类别:
A Virtually Supervised Web-Based Home Exercise Technology for Older Adults
针对老年人的虚拟监督的基于网络的家庭锻炼技术
  • 批准号:
    8726275
  • 财政年份:
    2013
  • 资助金额:
    $ 19.67万
  • 项目类别:
Interactive Telehealth and Auto-Biofeedback Sensor System for Individuals Who Use a Wheelchair
适用于轮椅使用者的交互式远程医疗和自动生物反馈传感器系统
  • 批准号:
    9345724
  • 财政年份:
    2013
  • 资助金额:
    $ 19.67万
  • 项目类别:
A Virtually Supervised Web-Based Home Exercise Technology for Older Adults
针对老年人的虚拟监督的基于网络的家庭锻炼技术
  • 批准号:
    8591613
  • 财政年份:
    2013
  • 资助金额:
    $ 19.67万
  • 项目类别:
Phase IIB: Portable Device for Telecare Monitoring of Elderly People
第二阶段:用于老年人远程护理监控的便携式设备
  • 批准号:
    9118830
  • 财政年份:
    2009
  • 资助金额:
    $ 19.67万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.67万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.67万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 19.67万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.67万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 19.67万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.67万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.67万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.67万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 19.67万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 19.67万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了